Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

ClinicalTrials.gov ID: NCT05127954

Public ClinicalTrials.gov record NCT05127954. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 8:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate long term safety and tolerability of ubrogepant in the acute treatment of migraine in pediatric participants. Ubrogepant is a drug approved for the acute treatment of migraine in adults. Pediatric participants (aged 6-17 years) with a history of migraine will be enrolled. Participants who completed the lead-in Study 3110-305-002, as well as those who were placebo responders and screen failed, will be eligible to enroll into this study. Around 1200 participants will be enrolled in the study at approximately 120 sites in the United States. Participants may receive ubrogepant oral tables to treat up to 8 migraine attacks of any intensity per month. There will be an option to take a second dose of study intervention (identical to initial dose), or rescue medication, starting 2 hours after the initial dose. The study duration will be up to 54 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The safety and tolerability of the treatment will be checked by medical assessments, blood tests, checking for adverse events and completing questionnaires.

Study identification

NCT ID
NCT05127954
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
1,200 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 14, 2022 (Actual)
Primary completion
Jan 2028 (Estimated)
Completion
Jan 2028 (Estimated)
Last update posted
Jul 20, 2025

2022 – 2028

United States locations

U.S. sites
109
U.S. states
35
U.S. cities
95
Facility City State ZIP Site status
Rehabilitation & Neurological Services /ID# 240054 Huntsville Alabama 35805-4046 —
The Center for Clinical Trials - Saraland /ID# 239448 Saraland Alabama 36571 —
Preferred Research Partners /ID# 238979 Little Rock Arkansas 72211 —
Advanced Research Center /ID# 238967 Anaheim California 92805 —
Neuro Pain Medical Center /ID# 239135 Fresno California 93710 —
Alliance for Research Alliance for Wellness /ID# 233497 Long Beach California 90807 —
Children's Hospital Los Angeles /ID# 239446 Los Angeles California 90027 —
Excell Research, Inc /ID# 233495 Oceanside California 92056 —
Paradigm Clinical Research - San Diego /ID# 269611 San Diego California 92108-1681 —
Lumos Clinical Research Center /ID# 239018 San Jose California 95124-4108 —
Pacific Clinical Research Management Group /ID# 238503 Upland California 91786 —
Sunwise Clinical Research /ID# 238458 Walnut Creek California 94596 —
Children's Hospital Colorado - Aurora /ID# 239838 Aurora Colorado 80045 —
IMMUNOe Research Centers /ID# 240846 Centennial Colorado 80112 —
MCB Clinical Research Centers /ID# 240999 Colorado Springs Colorado 80910 —
New England Institute for Clinical Research /ID# 239019 Stamford Connecticut 06905 —
Emerson Clinical Research Inst /ID# 238455 Washington D.C. District of Columbia 20011 —
Encore Medical Research of Boynton Beach LLC /ID# 248720 Boynton Beach Florida 33436-7245 —
Gulf Coast Clinical Research Center /ID# 233335 Fort Myers Florida 33912 —
Sarkis Clinical Trials /ID# 233493 Gainesville Florida 32607 —
Northwest Florida Clinical Research Group, LLC /ID# 244396 Gulf Breeze Florida 32561-4495 —
A.G.A Clinical Trials /ID# 238409 Hialeah Florida 33012 —
Encore Medical Research /ID# 247463 Hollywood Florida 33021 —
Advanced Research Institute of Miami /ID# 240712 Homestead Florida 33030-4613 —
Auzmer Research /ID# 241514 Lakeland Florida 33813-2768 —
Columbus Clinical Services, Llc /Id# 238968 Miami Florida 33125 —
My Preferred Research LLC /ID# 239020 Miami Florida 33155 —
Neurology & Pain Medicine /ID# 241860 Miami Florida 33186-7661 —
Medical Research Group of Central Florida /ID# 240711 Orange City Florida 32763 —
Clinical Associates of Orlando, LLC /ID# 272623 Orlando Florida 32819 —
Suncoast Clinical Research - Palm Harbor /ID# 233535 Palm Harbor Florida 34684 —
Asclepes Research Centers - Spring Hill /ID# 231872 Spring Hill Florida 34609-5692 —
University of South Florida- Neuroscience Institute /ID# 233420 Tampa Florida 33613 —
Encore Medical Research - Weston /ID# 248335 Weston Florida 33331 —
Pediatric Neurology and Epilepsy Specialists /ID# 233336 Winter Park Florida 32789-7111 —
Global Research Associates /ID# 243504 Atlanta Georgia 30315 —
Rare Disease Research, LLC /ID# 238833 Atlanta Georgia 30318-2512 —
Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 238852 Atlanta Georgia 30328 —
Coastal Georgia Child Neurology /ID# 240845 Brunswick Georgia 31520-1601 —
CenExcel iResearch LLC /ID# 239832 Decatur Georgia 30030 —
Velocity Clinical Research - Savannah /ID# 231873 Savannah Georgia 31406 —
Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 238454 Stockbridge Georgia 30281 —
Velocity Clinical Research - Boise /ID# 238978 Meridian Idaho 83642 —
Chicago Headache Center & Research Institute /ID# 254071 Chicago Illinois 60657 —
Accellacare - McFarland Clinic /ID# 238490 Ames Iowa 50010 —
College Park Family Care Center Overland Park /ID# 240707 Overland Park Kansas 66210-2761 —
Clinical Associates Midwest, LLC /ID# 274356 Overland Park Kansas 66214 —
Psychiatric Associates /ID# 240710 Overland Park Kansas 66221 —
Alliance for Multispecialty Research (AMR) - Wichita West /ID# 239829 Wichita Kansas 67205-1138 —
University of Kentucky Chandler Medical Center /ID# 233428 Lexington Kentucky 40536 —
Pharmasite Research, Inc. /ID# 233414 Baltimore Maryland 21208 —
Minneapolis Clinic of Neurology - Burnsville /ID# 238828 Burnsville Minnesota 55337-6732 —
MediSync Clinical Research Hattiesburg Clinic /ID# 239837 Petal Mississippi 39465-2932 —
Proven Endpoints LLC /ID# 240974 Ridgeland Mississippi 39157 —
Sharlin Health Neuroscience Research Center /ID# 238969 Ozark Missouri 65721-5315 —
Cognitive Clinical Trials (CCT) - Papillion /ID# 239835 Papillion Nebraska 68046-4131 —
Healthy Perspectives - Innovative Mental Health Services, PLLC /ID# 239441 Nashua New Hampshire 03060-3483 —
Hunterdon Neurology /ID# 248222 Annandale New Jersey 08801-3127 —
Goryeb Children's Hospital /ID# 239425 Morristown New Jersey 07960 —
CVS HealthHUB - Runnemede /ID# 240057 Runnemede New Jersey 08078-1034 —
Dent Neurologic Institute - Amherst /ID# 238415 Amherst New York 14226 —
Bioscience Research /ID# 239442 Mount Kisco New York 10549-3028 —
Modern Migraine MD /ID# 263140 New York New York 10001 —
North Suffolk Neurology /ID# 238457 Port Jefferson Station New York 11776-3387 —
SUNY Upstate Medical University /ID# 241140 Syracuse New York 13210 —
CVS HealthHUB - Charlotte /ID# 240842 Charlotte North Carolina 28210-8905 —
OnSite Clinical Solutions, LLC - Hickory /ID# 238946 Hickory North Carolina 28601 —
Patient Priority Clinical Sites, LLC /ID# 240051 Cincinnati Ohio 45215-2123 —
University of Cincinnati /ID# 238461 Cincinnati Ohio 45219 —
Cincinnati Childrens Hospital Medical Center /ID# 247491 Cincinnati Ohio 45229 —
Headache Center of Hope /ID# 244819 Cincinnati Ohio 45236-1875 —
Centricity Research Columbus /ID# 238832 Columbus Ohio 43213 —
CincyScience /ID# 233334 West Chester Ohio 45069 —
IPS Research Company /ID# 231876 Oklahoma City Oklahoma 73106 —
Providence Brain and Spine Institute /ID# 240050 Portland Oregon 97225-6625 —
Children's Hospital of Philadelphia - Main /ID# 241138 Philadelphia Pennsylvania 19104-4319 —
Frontier Clinical Research, LLC - Scottdale /ID# 239017 Scottdale Pennsylvania 15683 —
Frontier Clinical Research - Smithfield /ID# 238502 Smithfield Pennsylvania 15478 —
Coastal Pediatric Research /ID# 240708 Charleston South Carolina 29414-5834 —
Tribe Clinical Research LLC /ID# 239143 Greenville South Carolina 29607-4021 —
Duplicate_Premier Neurology, P.C. /ID# 233419 Greer South Carolina 29650 —
Access Clinical Trials, Inc. /ID# 238414 Nashville Tennessee 37203 —
UT Health Austin at Dell Children's Neurology Clinic /ID# 246570 Austin Texas 78723-3079 —
BioBehavioral Research of Austin /ID# 233427 Austin Texas 78759 —
Velocity Clinical Research, Austin /ID# 233406 Austin Texas 78759 —
Tekton Research - Beaumont /ID# 238407 Beaumont Texas 77706-3067 —
Relaro Medical Trials /ID# 241141 Dallas Texas 75243 —
Cedar Health Research /ID# 233403 Dallas Texas 75251-2202 —
3A Research - East El Paso /ID# 241665 El Paso Texas 79925-7945 —
Earle Research /ID# 238940 Friendswood Texas 77546 —
DM Clinical Research /ID# 238361 Houston Texas 77065 —
Houston Clinical Research Associates /ID# 246522 Houston Texas 77090-2633 —
Sante Clinical Research /ID# 248333 Kerrville Texas 78028-9640 —
FMC Science /ID# 240475 Lampasas Texas 76550 —
Livingspring Family Medical Center /ID# 252194 Mansfield Texas 76063-5622 —
AIM Trials /ID# 233425 Plano Texas 75093 —
Road Runner Research /ID# 238360 San Antonio Texas 78249-3538 —
Family Psychiatry of The Woodlands /ID# 238980 The Woodlands Texas 77381 —
ClinPoint Trials /ID# 238406 Waxahachie Texas 75165-1430 —
Pantheon Clinical Research /ID# 251475 Bountiful Utah 84010-4968 —
Highland Clinical Research /ID# 240053 Salt Lake City Utah 84124 —
University of Utah Health Hospital /ID# 239021 Salt Lake City Utah 84132 —
Neuropsychiatric Associates LLC/DBA Woodstock Research Center /ID# 240055 Woodstock Vermont 05091 —
Office of Maria Ona /ID# 239833 Franklin Virginia 23851 —
Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 239142 Norfolk Virginia 23507-1901 —
National Clinical Research /ID# 238419 Richmond Virginia 23294 —
Core Clinical Research /ID# 233421 Everett Washington 98201 —
Frontier Clinical Research - Kingwood /ID# 238459 Kingwood West Virginia 26537-9797 —
Mind+ Neurology /ID# 275538 Mequon Wisconsin 53092 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05127954, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2025 · Synced Nov 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05127954 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →